Synthetic triterpenoids, such as CDDO-MA, CDDO-EA, and CDDO-TFEA, activated NRF2/ARE-regulated genes, reduced oxidative stress in the stratum, and enhanced motor function and survival in rodent models of HD [156,157]. The gene discussed is NFE2L2; the disease is Huntington disease.